AAAAAA

   
Results: 1-16 |
Results: 16
A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptasegene promoter
Authors: Komata, T Koga, S Hirohata, S Takakura, M Germano, IM Inoue, M Kyo, S Kondo, S Kondo, Y
Citation: T. Komata et al., A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptasegene promoter, INT J ONCOL, 19(5), 2001, pp. 1015-1020
Combination therapy of 2-5A antisense against telomerase RNA and cisplatinfor malignant gliomas
Authors: Kondo, Y Komata, T Kondo, S
Citation: Y. Kondo et al., Combination therapy of 2-5A antisense against telomerase RNA and cisplatinfor malignant gliomas, INT J ONCOL, 18(6), 2001, pp. 1287-1292
Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisensetelomerase RNA
Authors: Koga, S Kondo, Y Komata, T Kondo, S
Citation: S. Koga et al., Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisensetelomerase RNA, GENE THER, 8(8), 2001, pp. 654-658
FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo
Authors: Koga, S Hirohata, S Kondo, Y Komata, T Takakura, M Inoue, M Kyo, S Kondo, S
Citation: S. Koga et al., FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo, ANTICANC R, 21(3B), 2001, pp. 1937-1943
Development of a traveling wave resonant ring of the JNC high-power, high-duty electron linac
Authors: Nomura, M Wang, YL Yamazaki, Y Hirano, K Kato, Y Ishikawa, T Komata, T Hiyama, T
Citation: M. Nomura et al., Development of a traveling wave resonant ring of the JNC high-power, high-duty electron linac, NUCL INST A, 463(1-2), 2001, pp. 42-49
CD4 ligation promotes the IL-4-independent development of IL-4-producing clones from naive CD4(+) T cells
Authors: Campbell, SB Komata, T Kelso, A
Citation: Sb. Campbell et al., CD4 ligation promotes the IL-4-independent development of IL-4-producing clones from naive CD4(+) T cells, J IMMUNOL, 167(10), 2001, pp. 5610-5619
Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter
Authors: Komata, T Kondo, Y Kanzawa, T Hirohata, S Koga, S Sumiyoshi, H Srinivasula, SM Barna, BP Germano, IM Takakura, M Inoue, M Alnemri, ES Shay, JW Kyo, S Kondo, S
Citation: T. Komata et al., Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter, CANCER RES, 61(15), 2001, pp. 5796-5802
Comparison of statistical power between 2x2 allele frequency and allele positivity tables in case-control studies of complex disease genes
Authors: Ohashi, J Yamamoto, S Tsuchiya, N Hatta, Y Komata, T Matsushita, M Tokunaga, K
Citation: J. Ohashi et al., Comparison of statistical power between 2x2 allele frequency and allele positivity tables in case-control studies of complex disease genes, ANN HUM GEN, 65, 2001, pp. 197-206
A novel telomerase-specific gene therapy: Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter
Authors: Koga, S Hirohata, S Kondo, Y Komata, T Takakura, M Inoue, M Kyo, S Kondo, S
Citation: S. Koga et al., A novel telomerase-specific gene therapy: Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter, HUM GENE TH, 11(10), 2000, pp. 1397-1406
Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53
Authors: Komata, T Kondo, Y Koga, S Ko, SC Chung, LWK Kondo, S
Citation: T. Komata et al., Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53, GENE THER, 7(24), 2000, pp. 2071-2079
Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component
Authors: Kondo, Y Koga, S Komata, T Kondo, S
Citation: Y. Kondo et al., Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component, ONCOGENE, 19(18), 2000, pp. 2205-2211
Differential effects of CD4 and CD8 engagement on the development of cytokine profiles of murine CD4(+) and CD8(+) T lymphocytes
Authors: Campbell, SB Komata, T Kelso, A
Citation: Sb. Campbell et al., Differential effects of CD4 and CD8 engagement on the development of cytokine profiles of murine CD4(+) and CD8(+) T lymphocytes, IMMUNOLOGY, 99(3), 2000, pp. 394-401
2-5A antisense telomerase RNA therapy for intracranial malignant gliomas'
Authors: Mukai, S Kondo, Y Koga, S Komata, T Barna, BP Kondo, S
Citation: S. Mukai et al., 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas', CANCER RES, 60(16), 2000, pp. 4461-4467
Tumor necrosis factor alpha 5 '-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis
Authors: Shibue, T Tsuchiya, N Komata, T Matsushita, M Shiota, M Ohashi, J Wakui, M Matsuta, K Tokunaga, K
Citation: T. Shibue et al., Tumor necrosis factor alpha 5 '-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis, ARTH RHEUM, 43(4), 2000, pp. 753-757
Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method
Authors: Matsushita, M Tsuchiya, N Shiota, M Komata, T Matsuta, K Zama, K Oka, T Juji, T Yamane, A Tokunaga, K
Citation: M. Matsushita et al., Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method, TISSUE ANTI, 54(6), 1999, pp. 578-584
Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus
Authors: Komata, T Tsuchiya, N Matsushita, M Hagiwara, K Tokunaga, K
Citation: T. Komata et al., Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus, TISSUE ANTI, 53(6), 1999, pp. 527-533
Risultati: 1-16 |